Your browser doesn't support javascript.
loading
Precision Combination Therapies Based on Recurrent Oncogenic Coalterations.
Li, Xubin; Dowling, Elisabeth K; Yan, Gonghong; Dereli, Zeynep; Bozorgui, Behnaz; Imanirad, Parisa; Elnaggar, Jacob H; Luna, Augustin; Menter, David G; Pilié, Patrick G; Yap, Timothy A; Kopetz, Scott; Sander, Chris; Korkut, Anil.
  • Li X; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dowling EK; Department of Statistics, Rice University, Houston, Texas.
  • Yan G; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dereli Z; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bozorgui B; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Imanirad P; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Elnaggar JH; Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, Louisiana.
  • Luna A; cBio Center, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Menter DG; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts.
  • Pilié PG; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Yap TA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kopetz S; Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sander C; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Korkut A; cBio Center, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
Cancer Discov ; 12(6): 1542-1559, 2022 06 02.
Article en En | MEDLINE | ID: mdl-35412613

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oncogenes / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oncogenes / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article